Published: 5 September 2019

Publications

Quarterly summary of recent safety communications

Prescriber Update 40(3): 58
September 2019

The table below is a summary of recent safety communications to healthcare professionals and consumers, published on the Medsafe website.

Date Communication Topic
16 August 2019 Monitoring Communication Cathejell Lignocaine 2% Gel and reports of issues when using this medicine
9 August 2019 Monitoring Communication Tramadol and opioid effects in breastfeeding babies – monitoring extended to 30 November 2019
9 August 2019 Dear Healthcare Professional Letter Femme-Tab (PDF 174 KB, 1 page) – brought in to cover stock shortage of combined oral contraceptive products (Microgynon, Levlen); information about blister pack differences
1 August 2019 Alert Communication Medsafe is issuing a warning to consumers to stop taking Go lean Detox and Go Detox - statement under section 98 of the Medicines Act 1981
31 July 2019 Monitoring Communication Update – Breast implants and anaplastic large cell lymphoma
17 July 2019 Dear Healthcare Professional Letter Ranbaxy-Cefaclor (PDF 222KB, 1 page) - Supply disruption for Cefaclor oral suspension and Acarbose tablets: difference in reconstitution volume for Keflor granules
3 July 2019 Dear Healthcare Professional Letter FluQuadri (PDF 109 KB, 2 pages) – Additional supply of FluQuadri influenza vaccine: differences in labelling and package inserts
28 June 2019 Publications Consumer Information Leaflet – Taking Lithium during pregnancy (PDF 319 KB, 2 pages)
11 June 2019 Dear Healthcare Professional Letter Xiaflex® (collagenase clostridium histolyticum) product discontinuation from 28 June 2019 (PDF 231 KB, 2 pages)
Hide menus
Show menus
0 1 2 4 5 6 7 9 [ /